NPI: 1285690248 · FT LAUDERDALE, FL 33316 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 04/26/2006
Authorized official WEY, SAMUEL controls 20+ related entities in our dataset. Read more
| Authorized Official | WEY, SAMUEL (VP, LICENSURE & CERTIFICATION) |
| NPI Enumeration Date | 04/26/2006 |
Other providers sharing the same authorized official: WEY, SAMUEL
| Provider | City | State | Total Paid |
|---|---|---|---|
| DVA HEALTHCARE RENAL CARE INC | NORTH HOLLYWOOD | CA | $16.47M |
| DVA HEALTHCARE RENAL CARE INC | DELANO | CA | $16.43M |
| DVA RENAL HEALTHCARE INC | LOS ANGELES | CA | $15.51M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $14.93M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.67M |
| DVA RENAL HEALTHCARE INC | OAKLAND | CA | $13.42M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.25M |
| DVA HEALTHCARE RENAL CARE INC | YUMA | AZ | $12.88M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $12.77M |
| DVA RENAL HEALTHCARE INC | FULLERTON | CA | $12.19M |
| DVA HEALTHCARE RENAL CARE INC | POMONA | CA | $11.96M |
| DVA RENAL HEALTHCARE INC | ANAHEIM | CA | $11.32M |
| DVA RENAL HEALTHCARE INC | ESCONDIDO | CA | $10.94M |
| DVA HEALTHCARE RENAL CARE INC | COSTA MESA | CA | $10.08M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $9.46M |
| DVA RENAL HEALTHCARE INC | VISALIA | CA | $9.22M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $8.83M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $8.56M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $7.78M |
| DVA RENAL HEALTHCARE INC | PALM SPRINGS | CA | $7.48M |
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 25,695 | $2.83M |
| 2019 | 32,240 | $4.72M |
| 2020 | 36,250 | $6.53M |
| 2021 | 31,256 | $2.18M |
| 2022 | 20,830 | $2.42M |
| 2023 | 6,701 | $433K |
| 2024 | 540 | $26K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 50,343 | 2,167 | $5.94M |
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 44,804 | 2,611 | $5.66M |
| J1270 | Injection, doxercalciferol, 1 mcg | 25,071 | 1,532 | $3.47M |
| J1756 | Injection, iron sucrose, 1 mg | 10,656 | 1,799 | $1.09M |
| A4657 | Syringe, with or without needle, each | 4,848 | 2,227 | $845K |
| 83970 | 2,784 | 1,703 | $375K | |
| 85048 | 2,835 | 1,774 | $331K | |
| 85041 | 2,860 | 1,790 | $329K | |
| 82728 | 2,135 | 1,386 | $254K | |
| 83550 | 2,205 | 1,420 | $252K | |
| 83540 | 2,224 | 1,431 | $252K | |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 1,279 | 725 | $150K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 703 | 431 | $90K |
| J0604 | Cinacalcet, oral, 1 mg, (for esrd on dialysis) | 587 | 264 | $69K |
| 82108 | 94 | 69 | $12K | |
| J0887 | Injection, epoetin beta, 1 microgram, (for esrd on dialysis) | 44 | 13 | $5K |
| G0008 | Administration of influenza virus vaccine | 21 | 19 | $3K |
| 90674 | 19 | 17 | $3K |